The latest analyst update trims Inogen’s fair value estimate from $13.00 to about $12.67 per share, a reduction of roughly 2.6%. Analysts are using this adjustment alongside the recent bullish ...
Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid first-quarter 2024 ...
Inogen’s business-to-business channel is benefiting from the accelerating adoption of portable oxygen concentrators (POCs), a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results